The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Statins Have Biphasic Effects on Angiogenesis
Abstract
Background — Statins inhibit HMG-CoA reductase to reduce the synthesis of cholesterol and isoprenoids that modulate diverse cell functions. We investigated the effect of the statins cerivastatin and atorvastatin on angiogenesis in vitro and in vivo. Methods and Results — Endothelial cell proliferation, migration, and differentiation were enhanced at low concentrations (0.005 to 0.01 μmol/L) but significantly inhibited at high statin concentrations (0.05 to 1 μmol/L). Antiangiogenic effects at high concentrations were associated with decreased endothelial release of vascular endothelial growth factor and increased endothelial apoptosis and were reversed by geranylgeranyl pyrophosphate. In murine models, inflammation-induced angiogenesis was enhanced with low-dose statin therapy (0.5 mg · kg −1 · d −1 ) but significantly inhibited with high concentrations of cerivastatin or atorvastatin (2.5 mg · kg −1 · d −1 ). Despite the fact that high-dose statin treatment was effective at reducing lipid levels in hyperlipidemic apolipoprotein E–deficient mice, it impaired rather than enhanced angiogenesis. Finally, high-dose cerivastatin decreased tumor growth and tumor vascularization in a murine Lewis lung cancer model. Conclusions — HMG-CoA reductase inhibition has a biphasic dose-dependent effect on angiogenesis that is lipid independent and associated with alterations in endothelial apoptosis and vascular endothelial growth factor signaling. Statins have proangiogenic effects at low therapeutic concentrations but angiostatic effects at high concentrations that are reversed by geranylgeranyl pyrophosphate. At clinically relevant doses, statins may modulate angiogenesis in humans via effects on geranylated proteins.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Angiogenesis in cancer and other diseases
Carmeliet, P., & Jain, R. K. (2000) · Nature · doi:10.1038/35025220 · Cited by 9,070
Angiogenesis in cancer, vascular, rheumatoid and other disease
Folkman, J. (1995) · Nature Medicine · doi:10.1038/nm0195-27 · Cited by 7,627
Kureishi, Y., Luo, Z., Shiojima, I., Bialik, A., Fulton, D., Lefer, D. J., Sessa, W. C., & Walsh, K. (2000) · Nature Medicine · doi:10.1038/79510 · Cited by 1,439
HMEC-1: Establishment of an Immortalized Human Microvascular Endothelial Cell Line
Ades, E. W., Candal, F. J., Swerlick, R. A., George, V. G., Summers, S., Bosse, D. C., & Lawley, T. J. (1992) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12613748 · Cited by 1,265
Current Perspectives on Statins
Maron, D. J., Fazio, S., & Linton, M. F. (2000) · Circulation · doi:10.1161/01.cir.101.2.207 · Cited by 1,213
Griffioen, A. W., & Molema, G. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01448-0 · Cited by 842
Nicotine stimulates angiogenesis and promotes tumor growth and atherosclerosis
Heeschen, C., Jang, J. J., Weis, M., Pathak, A., Kaji, S., Hu, R. S., Tsao, P. S., Johnson, F. L., & Cooke, J. P. (2001) · Nature Medicine · doi:10.1038/89961 · Cited by 800
Self-citationVascular endothelial growth factor enhances atherosclerotic plaque progression
Celletti, F. L., Waugh, J. M., Amabile, P. G., Brendolan, A., Hilfiker, P. R., & Dake, M. D. (2001) · Nature Medicine · doi:10.1038/86490 · Cited by 708
Moulton, K. S., Heller, E., Konerding, M. A., Flynn, E., Palinski, W., & Folkman, J. (1999) · Circulation · doi:10.1161/01.cir.99.13.1726 · Cited by 688
The evolving role of statins in the management of atherosclerosis
Vaughan, C. J., Gotto, A. M., & Basson, C. T. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00525-2 · Cited by 574
Ras Protein Farnesyltransferase: A Strategic Target for Anticancer Therapeutic Development
Rowinsky, E. K., Windle, J. J., & Von Hoff, D. D. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.11.3631 · Cited by 537
Sterols and Isoprenoids: Signaling Molecules Derived from the Cholesterol Biosynthetic Pathway
Edwards, P. A., & Ericsson, J. (1999) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.68.1.157 · Cited by 458
Endothelial Cell Apoptosis in Angiogenesis and Vessel Regression
Dimmeler, S., & Zeiher, A. M. (2000) · Circulation Research · doi:10.1161/01.res.87.6.434 · Cited by 425
Statin-Sensitive Dysregulated AT1 Receptor Function and Density in Hypercholesterolemic Men
Nickenig, G., Bäumer, A. T., Temur, Y., Kebben, D., Jockenhövel, F., & Böhm, M. (1999) · Circulation · doi:10.1161/01.cir.100.21.2131 · Cited by 395
Effects of statins on vascular wall: vasomotor function, inflammation, and plaque stability
Koh, K. (2000) · Cardiovascular Research · doi:10.1016/s0008-6363(00)00146-2 · Cited by 380
Dimmeler, S., Dernbach, E., & Zeiher, A. M. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01657-4 · Cited by 364
Blais, L., Desgagné, A., & LeLorier, J. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.15.2363 · Cited by 326
Inhibition of Monocyte Chemotactic Protein-1 Synthesis by Statins
Romano, M., Diomede, L., Sironi, M., Massimiliano, L., Sottocorno, M., Polentarutti, N., Guglielmotti, A., Albani, D., Bruno, A., Fruscella, P., et al. (2000) · Laboratory Investigation · doi:10.1038/labinvest.3780115 · Cited by 298
Lea, A. P., & McTavish, D. (1997) · Drugs · doi:10.2165/00003495-199753050-00011 · Cited by 290
Pedersen, T. R., Wilhelmsen, L., Færgeman, O., Strandberg, T. E., Thorgeirsson, G., Troedsson, L., Kristianson, J., Berg, K., Cook, T. J., Haghfelt, T., et al. (2000) · The American Journal of Cardiology · doi:10.1016/s0002-9149(00)00910-3 · Cited by 274
Nègre-Aminou, P., van Vliet, A. K., van Erck, M., van Thiel, G. C. F., van Leeuwen, R. E. W., & Cohen, L. H. (1997) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/s0005-2760(96)00184-1 · Cited by 212
Cilla, D. D., Whitfield, L. R., Gibson, D. M., Sedman, A. J., & Posvar, E. L. (1996) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(96)90218-0 · Cited by 204
Vincent, L., Chen, W., Hong, L., Mirshahi, F., Mishal, Z., Mirshahi-Khorassani, T., Vannier, J.-P., Soria, J., & Soria, C. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02337-7 · Cited by 201
Van Belle, E., Rivard, A., Chen, D., Silver, M., Bunting, S., Ferrara, N., Symes, J. F., Bauters, C., & Isner, J. M. (1997) · Circulation · doi:10.1161/01.cir.96.8.2667 · Cited by 199
Hernández-Perera, O., Pérez-Sala, D., Soria, E., & Lamas, S. (2000) · Circulation Research · doi:10.1161/01.res.87.7.616 · Cited by 188
Weis, M., Pehlivanli, S., Meiser, B. M., & von Scheidt, W. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01430-9 · Cited by 133
Self-citationFluvastatin Inhibits Matrix Metalloproteinase-1 Expression in Human Vascular Endothelial Cells
Ikeda, U., Shimpo, M., Ohki, R., Inaba, H., Takahashi, M., Yamamoto, K., & Shimada, K. (2000) · Hypertension · doi:10.1161/01.hyp.36.3.325 · Cited by 133
Angiogenesis Is Impaired by Hypercholesterolemia: Role of Asymmetric Dimethylarginine
Jang, J. J., Ho, H. –. V., Kwan, H. H., Fajardo, L. F., & Cooke, J. P. (2000) · Circulation · doi:10.1161/01.cir.102.12.1414 · Cited by 132
Self-citationBacterial Toxins Block Endothelial Wound Repair
Aepfelbacher, M., Essler, M., Huber, E., Sugai, M., & Weber, P. C. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.9.1623 · Cited by 102
Goligorsky, M. S., Budzikowski, A. S., Tsukahara, H., & Noiri, E. (1999) · Clinical and Experimental Pharmacology and Physiology · doi:10.1046/j.1440-1681.1999.03029.x · Cited by 99
Knapp, A. C., Huang, J., Starling, G. C., & Kiener, P. A. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00462-1 · Cited by 95
Gingras, D., Lamy, S., & Béliveau, R. (2000) · Biochemical Journal · doi:10.1042/bj3480273 · Cited by 65
Preclinical safety evaluation of cerivastatin, a novel HMG-CoA reductase inhibitor
von Keutz, E., & Schlüter, G. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00424-x · Cited by 58
Stein, E. A., Isaacsohn, J. L., Stoltz, R. R., Mazzu, A. L., Liu, M.-C., Lane, C., & Heller, A. H. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)00120-4 · Cited by 45
Biotransformation of cerivastatin in mice, rats, and dogs in vivo.
Boberg, M., Angerbauer, R., Kanhai, W. K., Karl, W., Kern, A., Radtke, M., & Steinke, W. (1998) · PubMed · Cited by 45
Lewis, R. P. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)80039-x · Cited by 31
(1998) · doi:10.1002/(sici)1097-0320(19980101)31:1<1::aid-cyto1>3.0.co;2-r
Cited by
PLEIOTROPIC EFFECTS OF STATINS
Liao, J. K., & Laufs, U. (2005) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.45.120403.095748 · Cited by 1,994
Pleiotropic Effects of Statins on the Cardiovascular System
Oesterle, A., Laufs, U., & Liao, J. K. (2017) · Circulation Research · doi:10.1161/circresaha.116.308537 · Cited by 1,247
Role of Akt Signaling in Vascular Homeostasis and Angiogenesis
Shiojima, I., & Walsh, K. (2002) · Circulation Research · doi:10.1161/01.res.0000022200.71892.9f · Cited by 1,012
Demierre, M.-F., Higgins, P. D. R., Gruber, S. B., Hawk, E., & Lippman, S. M. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1751 · Cited by 819
Vascular endothelial growth factor in eye disease
Penn, J. S., Madan, A., Caldwell, R. B., Bartoli, M., Caldwell, R. W., & Hartnett, M. E. (2008) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2008.05.001 · Cited by 762
Metadata
- Authors
- Weis, M., Heeschen, C., Glassford, A. J., & Cooke, J. P.
- Venue
- Circulation
- Published
- 2002-02-12
- Volume
- 105
- Issue
- 6
- Pages
- 739-745
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2035059839
- Cited by
- 680
- References
- 37
- FWCI
- 12.42
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.